DIAPER: Comparison of Two Bipolar Resector in Less Than 3cm Myoma Resection

Sponsor
Bicetre Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03402516
Collaborator
(none)
308
1
2
52.9
5.8

Study Details

Study Description

Brief Summary

Hysteroscopic resection of type 0, 1 or 2 myoma is frequent. The more frequent resector used for myoma resection is 26Fr hysteroscope. Actual miniaturization of resector led to 18.5Fr resector with a potential benefit because of less dilatation. These resectors are often used but no scientific evaluation has been performed.

Hypothesis of this non inferiority trial is that complete resection in a unique surgical time will be comparable with both resectors.

Condition or Disease Intervention/Treatment Phase
  • Device: 18.5 resector
  • Device: 26Fr resector
N/A

Detailed Description

Myoma type 0, 1 or 2 are often symptomatic (abnormal uterine bleeding or infertility) and hysteroscopic resections are thus frequent. This management is a minimally invasive surgery.

Usually, a 26Fr resectoscope is used and the main articles on this topic report hysteroscopie resections with a 26Fr resectoscope. Miniaturization of resector led to decrease in the size of resectors with a potential benefit because of a less important cervical dilatation and then a smaller risk of adverse events and an increase in the number of surgery under local anaesthesia.

Use of 18.5Fr resectors is more and more frequent but, to our knowledge, it has never been evaluated for benefit on cervical dilatation but also for rate of complete resection in one time, surgical length and rate of unbalanced input/output.

Intuitively, a smaller diameter could led to a less traumatic cervical dilatation but it could also led to an higher risk of incomplete treatment in one time and a longer surgical duration and a more frequent unbalanced input/output.

No study compare use of these two resectors (18.5 and 26Fr) all the more randomized. With 26Fr resector, the rate of complete resection in one time for less than 3cm myoma is around 90%. If this rate is higher with the 18.5Fr resector, the risk/benefit balance (including economic evaluation) won't be favorable to this use.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
308 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized trialRandomized trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Impact of the Diameter on the Performance of Two Bipolar Resectors 18.5Fr and 26Fr
Actual Study Start Date :
Nov 1, 2017
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Mar 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: 18.5Fr resector

Used of a 18.5Fr bipolar resector for hysteroscopic myomectomy. Cervical dilatation would be performed until Hegar bougie number 7 and then a classic hysteroscopic resection will be performed with a 18.5Fr bipolar resector.

Device: 18.5 resector
hysteroscopic myomectomy with a 18.5 Fr resector after cervical dilatation until Hegar bougie number 7

Active Comparator: 26Fr resector

Used of a 26Fr bipolar resector for hysteroscopic myomectomy. Cervical dilatation would be performed until Hegar bougie number 10 and then a classic hysteroscopic resection will be performed with a 24Fr bipolar resector.

Device: 26Fr resector
hysteroscopic myomectomy with a 26Fr resector after cervical dilatation until Hegar bougie number 10

Outcome Measures

Primary Outcome Measures

  1. Comparison with chi square test of rate of complete surgery in one time [3 years]

    Complete resection of myoma in one time

Secondary Outcome Measures

  1. Duration of surgery [3 years]

    Comparison of duration of surgery between 2 arms

  2. Rate of unbalanced in and out balance [3 years]

    Comparison of rate of unbalanced in and out balance between the 2 groups. A in/out balance higher than 500cc will be consider has unbalanced).

  3. Cost effectiveness analyses [3 years]

    Comparison of cost for complete resection of myoma between groups

  4. Complications rate [3 years]

    Comparison of complications rate (including cervical complications)

  5. Use of a 26Fr resector [3 years]

    Report of the rate of use of a 26Fr resector in the 18.5Fr group

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older than 18 years old

  • With a type 0,1 or 2 unique myoma requiring surgery

Exclusion Criteria:
  • No medical care

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Bicetre Le Kremlin-BicĂȘtre France 94275

Sponsors and Collaborators

  • Bicetre Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Capmas Perrine, Principal investigator, Bicetre Hospital
ClinicalTrials.gov Identifier:
NCT03402516
Other Study ID Numbers:
  • 2016-A01740-51
First Posted:
Jan 18, 2018
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Capmas Perrine, Principal investigator, Bicetre Hospital

Study Results

No Results Posted as of Jan 27, 2021